Publications by authors named "Michael Jann"

Claim this Profile
P
Prescription opioid use during pregnancy and risk for preterm birth or term low birthweight.
Julia D Interrante, Stacey L P Scroggs, Carol J Hogue, Jan M Friedman, Jennita Reefhuis, Michael W Jann

J Opioid Manag· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurocognitive effects associated with proprotein convertase subtilisin-kexin type 9 inhibitor use: a narrative review.
Wei C Yuet, Didi Ebert, Michael Jann

Ther Adv Drug Saf· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do Asians Patients Require Only Half of the Clozapine Dose Prescribed for Caucasians? A Critical Review.
Michael W Jann

Indian J Psychol Med· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Elective Course in Lesbian, Gay, Bisexual, and Transgender Health and Practice Issues.
Michael W Jann, Scott Penzak, Annesha White, Amulya Tatachar

Am J Pharm Educ· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Evolving Role of Pharmacists in Transgender Health Care.
Jan S Redfern, Michael W Jann

Transgend Health· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective Serotonin Reuptake Inhibitor Use and Risk of Gastrointestinal and Intracranial Bleeding.
Wei Cheng Yuet, Dhvani Derasari, Jon Sivoravong, David Mason, Michael Jann

J Am Osteopath Assoc· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Long-Acting Injectable Second-Generation Antipsychotics: An Update and Comparison Between Agents.
Michael W Jann, Scott R Penzak

CNS Drugs· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Acting Injectable Second-Generation Antipsychotics: An Update and Comparison Between Agents.
Michael W Jann, Scott R Penzak

CNS Drugs· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an enantioselective assay for simultaneous separation of venlafaxine and O-desmethylvenlafaxine by micellar electrokinetic chromatography-tandem mass spectrometry: Application to the analysis of drug-drug interaction.
Yijin Liu, Michael Jann, Chad Vandenberg, Chin B Eap, Shahab A Shamsi

J Chromatogr A· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and treatment of bipolar disorders in adults: a review of the evidence on pharmacologic treatments.
Michael W Jann

Am Health Drug Benefits· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unique collaboration between a private college of pharmacy and a private academic health system.
Nicole Metzger, Christopher Paciullo, Melissa Chesson, Michael W Jann, Janice Glascock

Hosp Pharm· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benzodiazepines: a major component in unintentional prescription drug overdoses with opioid analgesics.
Michael Jann, William Klugh Kennedy, Gaylord Lopez

J Pharm Pract· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinically significant drug interactions with atypical antipsychotics.
William Klugh Kennedy, Michael W Jann, Eric C Kutscher

CNS Drugs· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a chiral micellar electrokinetic chromatography-tandem mass spectrometry assay for simultaneous analysis of warfarin and hydroxywarfarin metabolites: application to the analysis of patients serum samples.
Xiaochun Wang, Jingguo Hou, Michael Jann, Yuen Yi Hon, Shahab A Shamsi

J Chromatogr A· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of a pharmacokinetic drug-drug interaction with venlafaxine extended-release/indinavir and desvenlafaxine extended-release/indinavir.
Michael W Jann, Vicky Spratlin, Kathryn Momary, Hailing Zhang, David Turner

Eur J Clin Pharmacol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced strategies for treatment of Parkinson's disease: the role of early treatment.
Michael W Jann

Am J Manag Care· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maternal treatment with opioid analgesics and risk for birth defects.
Cheryl S Broussard, Sonja A Rasmussen, Jennita Reefhuis, Jan M Friedman, Michael W Jann

Am J Obstet Gynecol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disposition of D-serine in healthy adults.
Guochuan E Tsai, Hsien-Yuan Lane, Chad M Vandenberg, Yi-Ching Liu, Priscilla Tsai, Michael W Jann

J Clin Pharmacol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antidepressant agents for the treatment of chronic pain and depression.
Michael W Jann, Julian H Slade

Pharmacotherapy· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endogenous histamine and cortisol levels in subjects with different histamine N-methyltransferase C314T genotypes : a pilot study.
Yuen Yi Hon, William J Jusko, Hong-Hao Zhou, Guo-Lin Chen, Dong Guo, Michael W Jann

Mol Diagn Ther· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of pharmacokinetic interaction between lamotrigine and olanzapine in healthy volunteers.
Michael W Jann, Yuen Yi Hon, Shahab A Shamsi, Jack Zheng, Eric A Awad

Pharmacotherapy· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced methylprednisolone clearance causing prolonged pharmacodynamics in a healthy subject was not associated with CYP3A5*3 allele or a change in diet composition.
Su-Jun Lee, William J Jusko, Christine G Salaita, Karim A Calis, Michael W Jann

J Clin Pharmacol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altered methylprednisolone pharmacodynamics in healthy subjects with histamine N-methyltransferase C314T genetic polymorphism.
Yuen Yi Hon, William J Jusko, Vicky E Spratlin, Michael W Jann

J Clin Pharmacol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-dependent alternations in the pharmacokinetics of olanzapine during coadministration of fluvoxamine in patients with schizophrenia.
Chih-Chiang Chiu, Hsien-Yuan Lane, Ming-Chyi Huang, Hui-Ching Liu, Michael W Jann

J Clin Pharmacol· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implications for atypical antipsychotics in the treatment of schizophrenia: neurocognition effects and a neuroprotective hypothesis.
Michael W Jann

Pharmacotherapy· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis